Article Information
History
- October 19, 2021.
Article Versions
- You are currently viewing Version 1 of this article (October 19, 2021 - 16:12).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sebastian Havervall, MD1,
- Ulrika Marking, MD1,
- Nina Greilert-Norin, RN1,
- Max Gordon, MD, PhD1,
- Henry Ng, MMSc1,2,
- Wanda Christ, MMSc3,
- Kim Blom, PhD1,4,
- Mia Phillipson, PhD2,
- Peter Nilsson, PhD5,
- Sophia Hober, PhD5,
- Jonas Klingström, PhD3,4,
- Sara Mangsbo, PhD6,
- Mikael Åberg, PhD#,7 and
- Charlotte Thålin, MD, PhD#,1,*
- 1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
- 2Department of Medical Cell Biology and SciLifeLab, Uppsala University, Uppsala, Sweden
- 3Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- 4Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden
- 5Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
- 6Department of Pharmacy and SciLifeLab, Uppsala University, Uppsala, Sweden
- 7Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden
- ↵*Corresponding author:
Charlotte Thålin, MD, PhD, Department of Clinical Sciences, Karolinska Insitutet, 18288 Danderyd Hospital, Sweden, Phone: +46 8123 55000, Mail: charlotte.thalin{at}ki.se
↵# These authors contributed equally